These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11888533

  • 1. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM.
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [Abstract] [Full Text] [Related]

  • 2. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V.
    Atherosclerosis; 2001 Nov; 159(1):187-92. PubMed ID: 11689220
    [Abstract] [Full Text] [Related]

  • 3. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.
    Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
    [Abstract] [Full Text] [Related]

  • 4. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1148-54. PubMed ID: 12117730
    [Abstract] [Full Text] [Related]

  • 5. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec 01; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 6. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1323-9. PubMed ID: 10807749
    [Abstract] [Full Text] [Related]

  • 7. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.
    Cuchel M, Wolfe ML, deLemos AS, Rader DJ.
    Atherosclerosis; 2002 Jul 01; 163(1):169-74. PubMed ID: 12048136
    [Abstract] [Full Text] [Related]

  • 8. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U, Williamson DW, Huang Y, Mahley RW.
    Clin Genet; 2005 Aug 01; 68(2):118-27. PubMed ID: 15996208
    [Abstract] [Full Text] [Related]

  • 9. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.
    Nephron; 2000 Apr 01; 84(4):333-41. PubMed ID: 10754410
    [Abstract] [Full Text] [Related]

  • 10. Human cholestryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors.
    Sy RG, Cutiongco EM, Punzalan FE, Santos RS, Geronimo FR, Tangco RV.
    J Atheroscler Thromb; 2007 Jun 01; 14(3):116-21. PubMed ID: 17587762
    [Abstract] [Full Text] [Related]

  • 11. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec 01; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 12. Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption.
    Corella D, Carrasco P, Amiano P, Arriola L, Chirlaque MD, Huerta JM, Martínez C, Martinez-Camblor P, Molina E, Navarro C, Quirós JR, Rodríguez L, Sánchez MJ, Ortega-Azorín C, Ros E, Sala N, González CA, Moreno C.
    Atherosclerosis; 2010 Aug 01; 211(2):531-8. PubMed ID: 20398902
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction.
    Cao M, Zhou ZW, Fang BJ, Zhao CG, Zhou D.
    Medicine (Baltimore); 2014 Nov 01; 93(26):e160. PubMed ID: 25474428
    [Abstract] [Full Text] [Related]

  • 14. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
    Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, Verna R.
    Clin Genet; 2001 Nov 01; 60(5):374-80. PubMed ID: 11903340
    [Abstract] [Full Text] [Related]

  • 15. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
    Freeman DJ, Samani NJ, Wilson V, McMahon AD, Braund PS, Cheng S, Caslake MJ, Packard CJ, Gaffney D.
    Eur Heart J; 2003 Oct 01; 24(20):1833-42. PubMed ID: 14563342
    [Abstract] [Full Text] [Related]

  • 16. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.
    Ikewaki K, Mabuchi H, Teramoto T, Yamada N, Oikawa S, Sasaki J, Takata K, Saito Y, Japan CETP Study Group.
    Metabolism; 2003 Dec 01; 52(12):1564-70. PubMed ID: 14669156
    [Abstract] [Full Text] [Related]

  • 17. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.
    Dullaart RP, Sluiter WJ.
    Pharmacogenomics; 2008 Jun 01; 9(6):747-63. PubMed ID: 18518852
    [Abstract] [Full Text] [Related]

  • 18. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men.
    Li TY, Zhang C, Asselbergs FW, Qi L, Rimm E, Hunter DJ, Hu FB.
    Am J Clin Nutr; 2007 Nov 01; 86(5):1524-9. PubMed ID: 17991668
    [Abstract] [Full Text] [Related]

  • 19. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
    van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM, DALI Study Group.
    Diabetes Care; 2003 Apr 01; 26(4):1216-23. PubMed ID: 12663600
    [Abstract] [Full Text] [Related]

  • 20. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.